BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform Life Science Investing
Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension Life Science Investing
Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital Life Science Investing
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales Life Science Investing
Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference Life Science Investing
Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures Life Science Investing
OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting Life Science Investing
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium Life Science Investing
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy Life Science Investing
Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
